Embecta Corp. (NASDAQ:EMBC) Receives Average Rating of “Reduce” from Analysts

Shares of Embecta Corp. (NASDAQ:EMBC) have earned a consensus recommendation of “Reduce” from the five ratings firms that are covering the firm, Marketbeat reports. Two analysts have rated the stock with a sell rating and three have given a hold rating to the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $11.00.

A number of research firms recently weighed in on EMBC. Zacks Research upgraded shares of Embecta from a “strong sell” rating to a “hold” rating in a report on Friday, July 17th. Weiss Ratings downgraded Embecta from a “sell (d+)” rating to a “sell (d)” rating in a research note on Monday, August 3rd.

Insider Buying and Selling

In related news, Director Milton Mayo Morris sold 6,293 shares of the company’s stock in a transaction on Friday, September 4th. The stock was sold at an average price of $5.88, for a total transaction of $37,002.84. Following the completion of the sale, the director owned 53,828 shares in the company, valued at approximately $316,508.64. This represents a 10.47% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Jeffrey Mann purchased 20,000 shares of the stock in a transaction that occurred on Wednesday, August 12th. The stock was bought at an average cost of $4.99 per share, with a total value of $99,800.00. Following the completion of the transaction, the insider directly owned 262,915 shares in the company, valued at $1,311,945.85. The trade was a 8.23% increase in their position. The SEC filing for this purchase provides additional information. Insiders purchased 70,000 shares of company stock worth $334,200 in the last ninety days. Corporate insiders own 1.30% of the company’s stock.

Institutional Trading of Embecta

Institutional investors have recently made changes to their positions in the company. One Wealth Advisors LLC bought a new position in shares of Embecta during the second quarter valued at about $33,000. Public Employees Retirement System of Ohio bought a new stake in Embecta in the 2nd quarter worth about $133,000. Sei Investments Co. bought a new stake in Embecta in the 1st quarter worth about $138,000. Alpine Global Management LLC purchased a new stake in Embecta in the 4th quarter valued at about $178,000. Finally, Parvin Asset Management LLC increased its stake in Embecta by 11,010.9% in the 1st quarter. Parvin Asset Management LLC now owns 20,333 shares of the company’s stock valued at $180,000 after buying an additional 20,150 shares during the last quarter. Institutional investors own 93.83% of the company’s stock.

Embecta Trading Up 5.0%

EMBC opened at $5.90 on Friday. The company’s fifty day moving average price is $4.75 and its two-hundred day moving average price is $5.36. Embecta has a 1-year low of $2.77 and a 1-year high of $14.91. The company has a market cap of $334.29 million, a price-to-earnings ratio of 3.99 and a beta of 0.86.

Embecta (NASDAQ:EMBC) last released its quarterly earnings data on Friday, August 7th. The company reported $0.56 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.29. The firm had revenue of $271.70 million for the quarter, compared to analyst estimates of $254.53 million. Embecta had a net margin of 8.59% and a negative return on equity of 19.25%. The business’s quarterly revenue was down 8.1% compared to the same quarter last year. During the same period last year, the firm earned $1.12 earnings per share. Embecta has set its FY 2026 guidance at 1.800-1.900 EPS. As a group, equities analysts forecast that Embecta will post 1.84 earnings per share for the current fiscal year.

Embecta Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 15th. Investors of record on Thursday, August 27th were given a dividend of $0.01 per share. The ex-dividend date of this dividend was Thursday, August 27th. This represents a $0.04 annualized dividend and a dividend yield of 0.7%. Embecta’s payout ratio is presently 2.70%.

About Embecta

Embecta Corporation (NASDAQ: EMBC) is a global diabetes-care company that develops and manufactures products designed to support insulin delivery and diabetes management. Its portfolio includes pen needles, insulin syringes, safety needles, lancets and other injection-related products used by people with diabetes and healthcare professionals.

The company also provides solutions intended to improve the safety, convenience and effectiveness of diabetes care, including connected and digital tools associated with insulin delivery.